Old breathalyzer has been remodeled to be able to diagnose the disease with surprising accuracy.

Metabolomx has developed a breathalyzer that can diagnose lung cancer in humans. Traditionally to determine if a patient has a lung cancer, doctors are often required to perform a biopsy that can be a costly procedure. With Metabolomx's new device, the process is non-invasive and each test only costs $75.

The machine is able to detect the chemical signature pattern of the cancer after the patient breathes into the device for five minutes. In a recent clinical trial, the machine was able to detect lung cancer with an 83% accuracy. Metabolomx is also looking to expand the the analysis beyond cancer to other diseases as well.

EXCLUSIVE MEMBER CONTENT
PSFK provides access to this article and every report, case-study, interview, and analysis that we publish for our members. PSFK Professional Membership also unlocks accessto unlimited customized research assistance and our database of over 100,000 insights on innovation trendspanning across eight industry sectors—from culture and brand to retail and customer experience.
Already a members? Log in